TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,023 Cr | ₹2,585 Cr | ₹3,266 Cr | ₹2,368 Cr | ₹1,803 Cr |
What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,023 Cr |
| Mar2025 | ₹2,585 Cr |
| Mar2024 | ₹3,266 Cr |
| Mar2023 | ₹2,368 Cr |
| Mar2022 | ₹1,803 Cr |
How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,023 Cr | 16.93 | |
| Mar2025 | ₹2,585 Cr | -20.85 | |
| Mar2024 | ₹3,266 Cr | 37.92 | |
| Mar2023 | ₹2,368 Cr | 31.34 | |
| Mar2022 | ₹1,803 Cr | - | |
Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹189,363.1 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| MANKIND PHARMA | ₹99,077.7 Cr | 1.4% | -2.9% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 1.2% |
-2.5% |
37.2% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses